News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Cartesian Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Selecta’s IPO Expected Next Week; Sixth Biotech in Massachusetts to Go Public This Year
June 20, 2016
·
2 min read
Business
Sanofi Adds Celiac Disease to the Menu With $300 Million Selecta Bet
May 13, 2015
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting
November 5, 2024
·
2 min read
Press Releases
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting
October 15, 2024
·
8 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants
October 4, 2024
·
1 min read
Drug Development
Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis
October 2, 2024
·
12 min read
Drug Development
Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
October 2, 2024
·
6 min read
Press Releases
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
September 9, 2024
·
6 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grant
September 6, 2024
·
1 min read
Press Releases
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
September 4, 2024
·
5 min read
Press Releases
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
August 26, 2024
·
1 min read
Business
Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 8, 2024
·
16 min read
